Editorial highlights trends and challenges in pharmacogenomics implementation and ethical principles, suggesting artificial intelligence and real-world evidence will drive personalized medicine.
Advances in genomic science, molecular diagnostics, and precision drug development are changing the landscape of healthcare. Pharmacogenomics, a once small scientific area, is quickly becoming a pillar of personalized medicine. This editorial addresses contemporary trends, translational challenges, and potential future directions to optimally harness genomic insights towards the clinic. It emphasises the importance of multidisciplinary approaches, global equity, and ethical principles to facilitate pharmacogenomics implementation, and looks ahead to artificial intelligence, multi-omics integration, and real-world evidence as the next major drivers of change.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: